Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Return on Assets (2019 - 2025)

Historic Return on Assets for Serina Therapeutics (SER) over the last 7 years, with Q3 2025 value amounting to 2.19%.

  • Serina Therapeutics' Return on Assets fell 8700.0% to 2.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.19%, marking a year-over-year decrease of 8700.0%. This contributed to the annual value of 2.24% for FY2024, which is 16400.0% down from last year.
  • Per Serina Therapeutics' latest filing, its Return on Assets stood at 2.19% for Q3 2025, which was down 8700.0% from 2.85% recorded in Q2 2025.
  • Serina Therapeutics' Return on Assets' 5-year high stood at 0.04% during Q4 2021, with a 5-year trough of 4.01% in Q4 2022.
  • Moreover, its 5-year median value for Return on Assets was 0.92% (2022), whereas its average is 1.4%.
  • Its Return on Assets has fluctuated over the past 5 years, first crashed by -39700bps in 2022, then soared by 36700bps in 2023.
  • Over the past 5 years, Serina Therapeutics' Return on Assets (Quarter) stood at 0.04% in 2021, then tumbled by -10761bps to 4.01% in 2022, then skyrocketed by 92bps to 0.34% in 2023, then tumbled by -630bps to 2.48% in 2024, then grew by 12bps to 2.19% in 2025.
  • Its Return on Assets stands at 2.19% for Q3 2025, versus 2.85% for Q2 2025 and 3.11% for Q1 2025.